Recent News

572 News Items found
Pictured: William Lee, Chris Sander & Nils Weinhold
In the Lab
In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.
Cancer biologist Andrea Ventura
In the Lab
MSK scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement.
A student asks a question at last year’s "Major Trends” seminar.
Event
Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.
Pictured: Pseudomonas aeruginosa
In the Lab
MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.
Pictured: Scott Lowe
In the Lab
In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.
Pictured: Experimental Brain Tumor
In the Lab
Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.
MSK and Hartford leadership holding certificate
Announcement
The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.
Pictured: Johanna Joyce
In the Lab
A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.
Lab mouse with cultured human pluripotent stem cells
In the Lab
Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will.
An origami crane illustrates the importance of RNA folding for regulating gene translation. The bolded sequences on the crane’s wings indicate the portion that is critical for the manufacture of many cancer-causing proteins.
In the Lab
Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.